Sugar Maple Asset Management’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-180
Closed -$4.19K 420
2024
Q4
$4.19K Buy
+180
New +$4.19K ﹤0.01% 237